Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia
| Autor: | Antonio R. Lucena-Araujo, Marcos André Cavalcanti Bezerra, Daniel Mazza Matos, Cíntia G. F. Machado, Mayara M Oliveira, Marinus M Lima, Juan L Coelho-Silva, Maria C Barros-Correia, Matheus F Bezerra, Adryanna T Andrade, Julia M Fonseca, Aleide S. Lima, Pedro L Franca-Neto, Maria A. Neves, Luany E Carvalho |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Oncology
Adult Male medicine.medical_specialty Disease free survival Adolescent Treatment outcome Disease-Free Survival 03 medical and health sciences Young Adult 0302 clinical medicine Internal medicine medicine Humans Young adult Survival analysis Aged Aged 80 and over business.industry Hematology Middle Aged Prognosis Survival Analysis CD56 Antigen Leukemia Myeloid Acute 030220 oncology & carcinogenesis Female Myeloid leukaemia Intermediate risk business 030215 immunology |
| Zdroj: | British journal of haematology. 176(3) |
| ISSN: | 1365-2141 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text